BDBM698704 BDBM698705::US20240317721, Example 301a

SMILES C=CC(=O)N1CC2(CC(n3nc(N4CC[C@@H](CN5CC6CC(C5)N6C(C)=O)CC4(C)C)c(-c4c(Cl)c(Cl)cc5[nH]ncc45)c3C)C2)C1

InChI Key InChIKey=WGCCCSCJMLQPHB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 698704   

TargetGTPase KRas [G12C](Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 698704BDBM698704(US20240317721, Example 301a | BDBM698705)
Affinity DataIC50: 5nMAssay Description:Assays were run using 384-well plates (781207/Greiner) in which one column was designated as the high signal (no inhibition) control, and contained D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetGTPase KRas [G12C](Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 698704BDBM698704(US20240317721, Example 301a | BDBM698705)
Affinity DataIC50: 1.90E+3nMAssay Description:Assays were run using 384-well plates (781207/Greiner) in which one column was designated as the high signal (no inhibition) control, and contained D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent